Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80
OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 4 Medicines Defect Notification: B. Braun Melsungen AG Recall: B
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited KingdomPublishedSeptember 23, 2026Last updatedSeptember 23, 2026Official source last checkedSeptember 23, 2026 at 1:05 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
Hazard
B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
What consumers should do
for Healthcare Professionals: Healthcare professionals are advised to continue using B. Braun Meropenem 1000 mg powder and solvent for solution for infusion in accordance with the approved Summary of Product Characteristics (SmPC). Although section 6 of the Patient Information Leaflet (PIL) incorrectly refers to 500 mg, the correct strength (1000 mg) is stated on the product packaging and in the relevant PIL heading. The identified issue is limited to incorrect information within sections 2 and 6 of the PIL, relating to the stated sodium content and product strength respectively. The issue does not affect the quality of the physical product formulation or efficacy of the medicinal product. Healthcare professionals are advised to review the information contained within this notification and take this into account when dispensing or administering this product, especially for new patients. Upon request, B Braun will provide hard copies of the updated PIL to wholesalers and pharmacies so that any packs can be supplemented with the correct PIL information. To request hard copies of the PIL, please contact medinfo.bbmuk@bbraun.com , or telephone 08002980299 with your details, i.e. addres
Official recall notice
Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: September 23, 2026
Read the official UK_MHRA recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
